JNJ vs LE · P/E 17, rev $49.37B vs P/E 63, rev $1.16B
Johnson & Johnson (JNJ) versus Lands’ End Inc (LE) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Lands’ End Inc (LE) is a apparel retail company listed on US.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported LE revenue for 2026-01-30 was $1.16B. Net income was $5.5M. Revenue was up 0.7% from 2025-01-31 to 2026-01-30. LE currently screens at market cap $347.1M and trailing P/E 62.6.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. LE currently screens at market cap $347.1M and trailing P/E 62.6.
Not investment advice. Open the JNJ and LE stock pages for the full models.
Not investment advice.